Skip to content
healthcare.dev

Cabergoline

NDC 0093-5420, Cabergoline, tablet, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-5420
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077750
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5420 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CABERGOLINE.5 mg/1

Pharmacologic classes

Ergolines [CS]; Ergot Derivative [EPC]

Package NDCNDC-11Package
0093-5420-88000935420881 BOTTLE in 1 CARTON (0093-5420-88) / 8 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/74b61e8a-7ae9-4996-85ec-df23c56de16f
  • NADAC price for package 00093542088

    GET /v1/drugs/nadac/00093542088

Use it

Look up 0093-5420 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5420 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-5420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.